CorMedix Inc. CRMD 深 滬
等待開盤 02-04 09:30:00 美东时间
8.12
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 8.12
- 總市值 6.34亿
- 52周最高 17.43
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 5.60
- 委 比 0.00%
- 總股本 7805.87万
- 歷史最高 52.00
- 量 比 0
- 振 幅 0.00%
- 歷史最低 0.73
- 每 手 1
- 風險率 2.03%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多CorMedix Therapeutics Announces $75M Buyback Plan
CorMedix Therapeutics (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced its Board of Directors has
02-02 21:38
CorMedix Hosts Analyst Day to Showcase Pipeline and Growth Drivers
CorMedix Hosts Analyst Day to Showcase Pipeline and Growth Drivers CorMedix Inc. will host an in-person and virtual analyst day in New York on February 10, 2026. The event will include presentations and panels featuring key opinion leaders and the company’s senior management, focusing on updates acr
01-29 21:31
美股大行评级 | 英特尔绩后获多家大行上调目标价；理想汽车、Mobileye、Meta、微软、甲骨文等遭下调目标价
今日重点评级关注：RBC Capital：维持Compass Pathways"跑赢大市"评级，目标价从16美元升至21美元；RBC Capital：维持GH Research"跑赢大市"评级，目标价从33美元升至40美元
01-26 14:32
Guardant Health, Jabil, NeoGenomics, Darden, Cormedix Insider Moves
Insiders have been trading these 5 stocks: (($GH)), (($JBL)), (($NEO)), (($DRI)...
01-24 21:00
U.S. RESEARCH ROUNDUP-Applied Materials, Procter & Gamble, RLI
U.S. RESEARCH ROUNDUP-Applied Materials, Procter & Gamble, RLI Jan 23 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Applied Materials, Procter & Gamble and RLI, on Friday. HIGHLIGHTS * Applied Materials Inc AMAT.O : Be
01-23 15:13
CorMedix Inc. Director Janet Dillione Reports Disposal of Common Shares
CorMedix Inc. Director Janet Dillione Reports Disposal of Common Shares Janet Dillione, Director of CorMedix Inc., reported a disposal of common shares of CorMedix Inc. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT) using
01-23 10:30
美股大行评级 | 奈飞绩后遭13家大行下调目标价；齐昂银行、美国合众银行获多家机构上调目标价
今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从9美元升至50美元；韦德布什：维持Ardelyx, Inc."跑赢大市"评级，目标价从16美元升至19美元
01-22 15:09
Where Cormedix Stands With Analysts
Cormedix (NASDAQ:CRMD) has been analyzed by 7 analysts in the last three months...
01-22 06:00
RBC Capital Maintains Outperform on Cormedix, Lowers Price Target to $13
RBC Capital analyst Leonid Timashev maintains Cormedix (NASDAQ:CRMD) with a Outperform and lowers the price target from $22 to $13.
01-21 22:38
U.S. RESEARCH ROUNDUP-IBM, KLA, WEX
U.S. RESEARCH ROUNDUP-IBM, KLA, WEX Jan 21 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including IBM, KLA and WEX, on Wednesday. HIGHLIGHTS * IBM IBM.N : JP Morgan raises target price to $312 from $290 * KLA Corp KLAC.O : Deut
01-21 16:26
